Androgen receptor content of normal and hyperplastic human prostate

John Trachtenberg, Piroska Bujnovszky, Patrick Walsh

Research output: Contribution to journalArticle

Abstract

In an effort to determine whether human benign prostatic hyperplasia (BPH) is characterized by an increase in androgen receptor content, the levels of nuclear and cytosolic androgen receptors were quantitated in normal prostatic tissue obtained from five young men (mean age ± SEM, 26 ± 3 yr) and i n hyperplastic (periurethral) and peripheral prostatic tissues obtained from nine older men (mean age, 62 ± 2 yr). There was no significant difference between the cytosolic or nuclear androgen receptor content of the hyperplastic, peripheral, or normal prostatic tissue. Thus, in this study we were unable to identify an increase in androgen receptor content in BPH. These findings fail to support the hypothesis that increases in androgen receptor content are involved in the pathogenesis of human BPH.

Original languageEnglish (US)
Pages (from-to)173-176
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume54
Issue number1
DOIs
StatePublished - 1982

Fingerprint

Androgen Receptors
Prostate
Prostatic Hyperplasia
Tissue
Cytoplasmic and Nuclear Receptors
Scanning electron microscopy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Androgen receptor content of normal and hyperplastic human prostate. / Trachtenberg, John; Bujnovszky, Piroska; Walsh, Patrick.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 54, No. 1, 1982, p. 173-176.

Research output: Contribution to journalArticle

@article{4e0e75da09fe411cb57ec1f78f921187,
title = "Androgen receptor content of normal and hyperplastic human prostate",
abstract = "In an effort to determine whether human benign prostatic hyperplasia (BPH) is characterized by an increase in androgen receptor content, the levels of nuclear and cytosolic androgen receptors were quantitated in normal prostatic tissue obtained from five young men (mean age ± SEM, 26 ± 3 yr) and i n hyperplastic (periurethral) and peripheral prostatic tissues obtained from nine older men (mean age, 62 ± 2 yr). There was no significant difference between the cytosolic or nuclear androgen receptor content of the hyperplastic, peripheral, or normal prostatic tissue. Thus, in this study we were unable to identify an increase in androgen receptor content in BPH. These findings fail to support the hypothesis that increases in androgen receptor content are involved in the pathogenesis of human BPH.",
author = "John Trachtenberg and Piroska Bujnovszky and Patrick Walsh",
year = "1982",
doi = "10.1210/jcem-54-1-17",
language = "English (US)",
volume = "54",
pages = "173--176",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Androgen receptor content of normal and hyperplastic human prostate

AU - Trachtenberg, John

AU - Bujnovszky, Piroska

AU - Walsh, Patrick

PY - 1982

Y1 - 1982

N2 - In an effort to determine whether human benign prostatic hyperplasia (BPH) is characterized by an increase in androgen receptor content, the levels of nuclear and cytosolic androgen receptors were quantitated in normal prostatic tissue obtained from five young men (mean age ± SEM, 26 ± 3 yr) and i n hyperplastic (periurethral) and peripheral prostatic tissues obtained from nine older men (mean age, 62 ± 2 yr). There was no significant difference between the cytosolic or nuclear androgen receptor content of the hyperplastic, peripheral, or normal prostatic tissue. Thus, in this study we were unable to identify an increase in androgen receptor content in BPH. These findings fail to support the hypothesis that increases in androgen receptor content are involved in the pathogenesis of human BPH.

AB - In an effort to determine whether human benign prostatic hyperplasia (BPH) is characterized by an increase in androgen receptor content, the levels of nuclear and cytosolic androgen receptors were quantitated in normal prostatic tissue obtained from five young men (mean age ± SEM, 26 ± 3 yr) and i n hyperplastic (periurethral) and peripheral prostatic tissues obtained from nine older men (mean age, 62 ± 2 yr). There was no significant difference between the cytosolic or nuclear androgen receptor content of the hyperplastic, peripheral, or normal prostatic tissue. Thus, in this study we were unable to identify an increase in androgen receptor content in BPH. These findings fail to support the hypothesis that increases in androgen receptor content are involved in the pathogenesis of human BPH.

UR - http://www.scopus.com/inward/record.url?scp=85003166521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003166521&partnerID=8YFLogxK

U2 - 10.1210/jcem-54-1-17

DO - 10.1210/jcem-54-1-17

M3 - Article

C2 - 6172440

AN - SCOPUS:85003166521

VL - 54

SP - 173

EP - 176

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -